151P Clinical outcome and preliminary immune analysis of phase II clinical trial of combination of tocilizumab with ipilimumab and nivolumab for patients with treatment naïve metastatic melanoma. (December 2022) - Montazari, E.J.J.; Abdel-Wahab, N.; Johnson, D.; Spillson, C.; Elsayes, K.M.; Duan, F.; Yadav, S.; Allison, J.; Sharma, P.; Diab, A.